Advertisement
Advertisement

DFTX

D

Definium Therapeutics, Inc. Common Shares

22.05
USD
Sponsored
-1.15
-4.96%
May 08, 16:00 UTC -4
Closed
exchange

Pre-Market

22.13

+0.08
+0.36%

Definium Therapeutics, Inc. Common Shares Profile

About

Definium Therapeutics, Inc. is developing therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction. Definium Therapeutics Inc., formerly known as Mind Medicine Inc., is based in NEW YORK.

Info & Links

CEO

Robert Barrow

Headquarters

ONE WORLD TRADE CENTER, SUITE 8500
NEW YORK, NY 10007, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.definiumtx.com

Auditor

KPMG LLP

Share holders

83

Employees

106

Definium Therapeutics, Inc. Common Shares Statistics

Valuation Measures

Market Capitalization2

2.41B

Enterprise Value

2.19B

Enterprise Value/EBITDA(ttm)

-11.41

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

6.37

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-82.07%

Return on Invested Capital(ttm)

-81.27%

Return on Assets(ttm)

-58.73%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-192.18M

Net Income Available to Common(ttm)

-237.54M

Diluted EPS(ttm)

-2.13

Share Statistics

Beta (5Y Monthly)

2.44

52-Week Change

--

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

109.07M

Dividend Yield

0.00%

Float4

97.44M

% Held by Insiders

2.26%

% Held by Institutions

27.91%

Balance Sheet

Total Cash(mrq)

373.42M

Total Cash Per Share(mrq)

3.42

Total Debt(mrq)

40.77M

Total Debt/Equity(mrq)

12.21%

Current Ratio(mrq)

6.29%

Quick Ratio(mrq)

6.29%

Book Value Per Share(mrq)

3.36

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.47

Free Cash Flow(ytd)

-131.56M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement